Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on Immunotherapy in Lung Cancer July 2019

03 - 04 Jul 2019

Zurich, Switzerland

ESMO Advanced Course on Lung Cancer 1000x1000

Presentations from all ESMO Advanced Courses are open to all according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Learning objectives

  • Understanding the key players in tumour immunology
  • Getting up-to-date on the role of immunotherapy in advanced NSCLC
  • The role of biomarkers in selecting NSCLC patients for IT
  • Mechanism of combining angiogenesis inhibition with checkpoint inhibition
  • Management of IT toxicity and use of IT in specific subgroups of patients

 

Hide
Filter by:

There are 11 resources available

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings